雜志介紹

Infectious Diseases And Therapy雜志介紹

《Infectious Diseases And Therapy》是一本以(yi)English為(wei)主的(de)開(kai)放獲取(qu)(qu)國際(ji)優(you)秀期刊(kan)(kan)，中(zhong)文名稱傳染(ran)病與治療，本刊(kan)(kan)主要出版(ban)、報道醫學(xue)-INFECTIOUS DISEASES領(ling)域的(de)研究動(dong)態以(yi)及在該領(ling)域取(qu)(qu)得的(de)各方(fang)面的(de)經驗和科研成(cheng)果，介(jie)紹(shao)該領(ling)域有關(guan)本專業的(de)最(zui)新進展，探討(tao)行(xing)業發(fa)展的(de)思(si)路和方(fang)法，以(yi)促進學(xue)術信息(xi)交流，提(ti)高行(xing)業發(fa)展。該刊(kan)(kan)已被國際(ji)權威(wei)數據庫SCIE收錄，為(wei)該領(ling)域相關(guan)學(xue)科的(de)發(fa)展起(qi)到了良好(hao)的(de)推動(dong)作用，也得到了本專業人(ren)員的(de)廣泛認(ren)可。該刊(kan)(kan)最(zui)新影(ying)響因(yin)子為(wei)4.7，最(zui)新CiteScore 指數為(wei)8.6。

本刊近期中國(guo)學者發(fa)表(biao)的論文主要有：

• Non-invasive Assessment of Liver Fibrosis Regression in Patients with Chronic Hepatitis B: A Retrospective Cohort Study

  Author: Xu, Wei; Hu, Qiankun; Chen, Chong; Li, Weixia; Li, Qiang; Chen, Liang

• Retrospective Analysis of Epidemiology, Risk Factors, and Outcomes of Health Care-Acquired Carbapenem-Resistant Klebsiella pneumoniae Bacteremia in a Chinese Tertiary Hospital, 2010-2019

  Author: Li, Meng; Yang, Shanshan; Yao, Hongwu; Liu, Yunxi; Du, Mingmei

• Association Between Lactate and 28-Day Mortality in Elderly Patients with Sepsis: Results from MIMIC-IV Database

  Author: He, Liudang; Yang, Donghua; Ding, Qiong; Su, Yingjie; Ding, Ning

• Comparison of the Distribution and Changes in the Antibiotic Resistance of Clinical Bacterial Isolates from the Lower Respiratory Tract of Children in Shenzhen Before the Epidemic, During the Epidemic, and During the Period of Normalized Prevention and Control of COVID-19

  Author: Meng, Qing; Li, Wujiao; Jiang, Hanfang; Yan, Huimin; Wang, Heping; Ye, Binjun; Zhou, Lintao; Chen, Yunsheng

英文介紹

Infectious Diseases And Therapy雜志英文介紹

Infectious Diseases and Therapy is an international, open access, peer-reviewed, rapid publication journal dedicated to the publication of high-quality clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of infectious disease therapies and interventions, including vaccines and devices. Studies relating to diagnostic products and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.

Areas of focus include, but are not limited to, bacterial and fungal infections, viral infections (including HIV/AIDS and hepatitis), parasitological diseases, tuberculosis and other mycobacterial diseases, vaccinations and other interventions, and drug-resistance, chronic infections, epidemiology and tropical, emergent, pediatric, dermal and sexually-transmitted diseases.